Rivopharm’s diverse and highly complementary product portfolio counts over a 100 molecules, with more than 2000 SKUs, targeting a wide spectrum of chronic and acute treatments.
We aim to a continuous expansion selecting strategical projects in cooperation with our highly-qualified Research & Development team and we are now present, directly and through our associates and partners, in more than 60 countries around the world, providing healthcare to over one fourth of the entire European population.
Our capabilities span generic prescribed drugs (RXs), over-the-counter (OTC) and food supplements, mainly available in different oral dosage forms like tablets and capsules, packed in customized blisters and bottles.
The therapeutic segments covered by our portfolio include psychiatry, cardiology, cardiovascular, CNS, diabetes, gastroenterology, ophthalmology, urology, gynecology, respiratory and oncology.
The offer for the listed products is only proposed for those countries where no patent protection exists. Please, contact us for further information regarding our product pipeline and products in development.